vTv Therapeutics
VTVT
37 hedge funds and large institutions have $32.9M invested in vTv Therapeutics in 2015 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
52.1% more ownership
Funds ownership: 0% → 52.1% (+52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$8.3M |
| 2 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
+$6.75M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$3.93M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.18M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$3.11M |
Top Sellers
VTVT Hedge Fund Activity: Q3 2015 in Review
37 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2015, worth a combined $32.9M.
Buyers outnumbered sellers: 37 funds opened new VTVT positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $8.3M.
- 37 institutional investors held vTv Therapeutics (VTVT) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $32.9M of vTv Therapeutics stock for Q3 2015.
- 37 funds opened new vTv Therapeutics positions in Q3 2015 and 0 closed out, a net change of +37 holders.
- The largest vTv Therapeutics buyer in Q3 2015 was Franklin Resources, an estimated $8.3M added.
Based on aggregated 13F filings for Q3 2015.